[Surfactant-dependent atelectasis in pulmonary tuberculosis]. 1998

V V Erokhin, and L N Lepekha
Central Research Institute of Tuberculosis, Moscow.

Using mathematic modelling of the secretion function of type II alveolocytes of the right lung intercellular surfactant production in treated and not treated rabbits with multi cavernous tuberculosis of the lung was evaluated. Correlation between its disorders and frequency of development and dissemination of atelectatic changes in the organ was revealed. Surfactant-dependent character of alveoli atelectasis in animals receiving a combination of antituberculosis drugs (isoniazide plus rifampycin plus etambutol), a direct effect of these drugs on membranes of the granular endoplasmic reticulum, formation of secretion granules was demonstrated. Daily intravenous administration of amboxol (25 mg/kg) for 14 days had a protective effect on type II alveolocytes, activated surfactant production, prevented alveoli from atelectasis.

UI MeSH Term Description Entries
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D001261 Pulmonary Atelectasis Absence of air in the entire or part of a lung, such as an incompletely inflated neonate lung or a collapsed adult lung. Pulmonary atelectasis can be caused by airway obstruction, lung compression, fibrotic contraction, or other factors. Atelectasis, Congestive,Lung Collapse,Atelectasis,Compression Atelectasis,Compression Pulmonary Atelectasis,Congestive Atelectasis,Congestive Pulmonary Atelectasis,Contraction Pulmonary Atelectasis,Postoperative Pulmonary Atelectasis,Resorption Atelectasis,Resorption Pulmonary Atelectasis,Atelectases,Atelectases, Compression,Atelectases, Compression Pulmonary,Atelectases, Congestive,Atelectases, Congestive Pulmonary,Atelectases, Contraction Pulmonary,Atelectases, Postoperative Pulmonary,Atelectases, Pulmonary,Atelectases, Resorption,Atelectases, Resorption Pulmonary,Atelectasis, Compression,Atelectasis, Compression Pulmonary,Atelectasis, Congestive Pulmonary,Atelectasis, Contraction Pulmonary,Atelectasis, Postoperative Pulmonary,Atelectasis, Pulmonary,Atelectasis, Resorption,Atelectasis, Resorption Pulmonary,Collapse, Lung,Compression Atelectases,Compression Pulmonary Atelectases,Congestive Atelectases,Congestive Pulmonary Atelectases,Contraction Pulmonary Atelectases,Postoperative Pulmonary Atelectases,Pulmonary Atelectases,Pulmonary Atelectases, Compression,Pulmonary Atelectases, Congestive,Pulmonary Atelectases, Contraction,Pulmonary Atelectases, Postoperative,Pulmonary Atelectases, Resorption,Pulmonary Atelectasis, Compression,Pulmonary Atelectasis, Congestive,Pulmonary Atelectasis, Contraction,Pulmonary Atelectasis, Postoperative,Pulmonary Atelectasis, Resorption,Resorption Atelectases,Resorption Pulmonary Atelectases
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

V V Erokhin, and L N Lepekha
January 1964, Anesthesiology,
V V Erokhin, and L N Lepekha
May 1970, Laval medical,
V V Erokhin, and L N Lepekha
May 1951, Tubercle,
V V Erokhin, and L N Lepekha
January 1950, Pediatricke listy,
V V Erokhin, and L N Lepekha
January 1971, Verhandlungen der Anatomischen Gesellschaft,
V V Erokhin, and L N Lepekha
January 1953, Vojnosanitetski pregled,
V V Erokhin, and L N Lepekha
January 1963, Giornale italiano della tubercolosi e delle malattie del torace,
V V Erokhin, and L N Lepekha
July 1978, Problemy tuberkuleza,
V V Erokhin, and L N Lepekha
April 1946, Hospital (Rio de Janeiro, Brazil),
V V Erokhin, and L N Lepekha
June 1956, Gruzlica (Warsaw, Poland : 1926),
Copied contents to your clipboard!